+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 60Years
FEMALE
ID07793630

Randomized Trial Comparing Foam Sclerotherapy Alone Versus Combined Foam and Transdermal Laser for Treating Reticular Veins and Telangiectasias

Led by University of Sao Paulo · Updated on 2026-10-05

70

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two treatments for reticular veins and telangiectasias, which are common signs of chronic venous disease classified as CEAP C1. These vein issues, often seen as cosmetic concerns, can cause discomfort and impact quality of life and body image. The study compares isolated polidocanol foam sclerotherapy alone versus a combined Cryo-Laser After Foam CLaF technique that adds transdermal laser treatment to the foam sclerotherapy. This prospective, randomized, controlled clinical trial includes 70 women aged 18 to 60 with bilateral, symmetrical vein conditions.

CONDITIONS

Brief Title

Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias

Research Team

C

Cecília S Ulacia, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here